Literature DB >> 1562251

Cataract extraction after proton beam irradiation for malignant melanoma of the eye.

E S Gragoudas1, K M Egan, P G Arrigg, J M Seddon, R J Glynn, J E Munzenrider.   

Abstract

We evaluated visual outcome and risk of metastases in patients who underwent cataract extraction after protonbeam irradiation of a uveal melanoma. A total of 84 patients underwent cataract extraction between 2 months and 11 years after irradiation. One year after cataract extraction, approximately half of the patients had visual acuity of 20/100 or better, and approximately one third had an acuity of 20/40 or better. Larger tumor size was highly correlated with poor visual outcome 1 year after extraction. Six patients underwent enucleation after cataract removal, five due to blind, painful eyes and one due to continued growth of a previously undiagnosed ring melanoma. The rate of metastases was not higher among patients who underwent cataract extraction (adjusted rate ratio, 0.83). Results suggest that cataract extraction offers improvement of vision in selected eyes previously irradiated for a uveal melanoma, without adding to the risk of metastases among patients undergoing the procedure.

Entities:  

Mesh:

Year:  1992        PMID: 1562251     DOI: 10.1001/archopht.1992.01080160053029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  A non-contiguous recurrence of the ciliary body melanoma-is cataract surgery a risk factor?

Authors:  Biljana Kuzmanović Elabjer; Mladen Bušić; Mirjana Bjeloš; Daliborka Miletić; Nenad Vukojević
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

4.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

Review 5.  The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review.

Authors:  Geertruida E Bekkering; Anne W S Rutjes; Vasiliy V Vlassov; Daniel M Aebersold; Konrade von Bremen; Peter Jüni; Jos Kleijnen
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

6.  Cataract development in patients treated with proton beam therapy for uveal melanoma.

Authors:  Ira Seibel; Dino Cordini; Annette Hager; Aline I Riechardt; Matus Rehak; Alexander Böker; Dirk Böhmer; Jens Heufelder; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-26       Impact factor: 3.117

7.  Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation.

Authors:  Chryssanthi Koutsandrea; Marilita M Moschos; Michael Dimissianos; Gerasimos Georgopoulos; Ioannnis Ladas; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-12

Review 8.  Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.

Authors:  Juliette Thariat; Arnaud Martel; Alexandre Matet; Olivier Loria; Laurent Kodjikian; Anh-Minh Nguyen; Laurence Rosier; Joël Herault; Sacha Nahon-Estève; Thibaud Mathis
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.